Clinical Professor Bridget Wilcken AM

Clinical Professor
Paediatrics & Child Health, Children's Hospital, Westmead

C29 - Children's Hospital Westmead
The University of Sydney
NSW 2006 Australia

T: +61 2 9845 3654 / +61 2 9845 3650
F: +61 2 9845 3376
E: Send message

On this page

Themes | Grants | Keywords | Publications

 

Current national competitive grants*

2013

Infant thyroid hormone levels and long-term child educational outcomes
Nassar N, Roberts C, Wilcken B, Martin A, Jack M, Wiley V, Algert C
NHMRC Project Grant ($476,257 over 3 years)

* Grants administered through the University of Sydney

Keywords

Cystic fibrosis; Amino acids; Genetic diseases; Preventive health services

Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008

2013

   
  • Wilcken, B. (2013), Newborn Screening: Gaps in the Evidence. Science. 342(6155), 197-198. [Abstract]
  • Wilcken, B. (2013), Congenital adrenal hyperplasia: one hundred years of data. The Lancet. Diabetes & Endocrinology. 1(1), 4-5. [Abstract]
  • Tchan, M., Westbrook, M., Wilcox, G., Cutler, R., Smith, N., Penman, R., Strauss, B., Wilcken, B. (2013), The Management of Pregnancy in Maple Syrup Urine Disease: Experience with Two Patients. JIMD Reports. 10, 113-117. [Abstract]
  • Christie, L., Wotton, T., Bennetts, B., Wiley, V., Wilcken, B., Rogers, C., Boyle, J., Turner, C., Hansen, J., Hunter, M., Goel, H., Field, M. (2013), Maternal attitudes to newborn screening for fragile X syndrome. American Journal of Medical Genetics. Part A. 161A(2), 301-311. [Abstract]
  • Tchan, M., Wilcken, B., Christodoulou, J. (2013), The mild form of menkes disease: a 34 year progress report on the original case. JIMD Reports. 9, 81-84. [Abstract]
  • Wilcken, B. (2013), Congenital adrenal hyperplasia: One hundred years of data. The Lancet Diabetes and Endocrinology. , 4-5.

2012

   
  • Grünert, S., Stucki, M., Morscher, R., Suormala, T., Bürer, C., Burda, P., Christensen, E., Ficicioglu, C., Herwig, J., Kölker, S., Möslinger, D., Pasquini, E., Santer, R., Schwab, K., Wilcken, B., Fowler, B., Yue, W., Baumgartner, M. (2012), 3-Methylcrotonyl-CoA Carboxylase Deficiency: Clinical, biochemical, enzymatic and molecular studies in 88 individuals. Orphanet Journal of Rare Diseases. 7(1), 31. [Abstract]
  • Wilcken, B. (2012), Leukoencephalopathies associated with disorders of cobalamin and folate metabolism. Seminars in Neurology. 32(1), 68-74. [Abstract]
  • Wilcken, B. (2012), Screening for disease in the newborn: the evidence base for blood-spot screening. Pathology. 44(2), 73-9. [Abstract]
  • Bennett, M., Rinaldo, P., Wilcken, B., Pass, K., Watson, M., Wanders, R. (2012), Newborn Screening for Metabolic Disorders: How Are We Doing, and Where Are We Going?. Clinical Chemistry. 58(2), 324-331. [Abstract]
  • Fletcher, J., Wilcken, B. (2012), Neonatal screening for lysosomal storage disorders. Lancet. 379(9813), 294-295. [Abstract]
  • Wilson, C., Kerruish, N., Wilcken, B., Wiltshire, E., Bendikson, K., Webster, D. (2012), Diagnosis of disorders of intermediary metabolism in New Zealand before and after expanded newborn screening: 2004-2009. New Zealand Medical Journal. 125(1348), 42-50. [Abstract]
  • Wilcken, B. (2012), Clinical practice and the development of evidence. Journal of inherited metabolic disease. 35(1), 3-4. [Abstract]
  • Alodaib, A., Carpenter, K., Wiley, V., Wotton, T., Christodoulou, J., Wilcken, B. (2012), Homocysteine Measurement in Dried Blood Spot for Neonatal Detection of Homocystinurias. In: JIMD Reports - Case and Research Reports, 2012/2. (pp.1-6).Germany: Springer.

2011

   
  • Gaskin, K., Wilcken, B. (2011), Long-term outcomes for patients with cystic fibrosis in Australia. The Medical journal of Australia. 195(7), 370-1. [Abstract]
  • Alodaib, A., Carpenter, K., Wiley, V., Sim, K., Christodoulou, J., Wilcken, B. (2011), An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples. Annals of clinical biochemistry. 48(5), 468-70. [Abstract]
  • Wilcken, B. (2011), Ethical issues in genetics. Journal of Paediatrics and Child Health. 47(9), 668-671. [Abstract]
  • Bijarnia, S., Wilcken, B., Wiley, V. (2011), Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. Journal of inherited metabolic disease. 34(3), 827-33. [Abstract]
  • Wilcken, B. (2011), Newborn screening: how are we travelling, and where should we be going?. Journal of inherited metabolic disease. 34(3), 569-74. [Abstract]
  • Kölker, S., Christensen, E., Leonard, J., Greenberg, C., Boneh, A., Burlina, A., Burlina, A., Dixon, M., Duran, M., García Cazorla, A., Goodman, S., Koeller, D., Kyllerman, M., Mühlhausen, C., Müller, E., Okun, J., Wilcken, B., Hoffmann, G., Burgard, P. (2011), Diagnosis and management of glutaric aciduria type I - revised recommendations. Journal of Inherited Metabolic Disease. 34(3), 677-694. [Abstract]
  • McHugh, D., Cameron, C., Abdenur, J., Abdulrahman, M., Adair, O., Al Nuaimi, S., Åhlman, H., Allen, J., Antonozzi, I., Archer, S., Au, S., Auray-Blais, C., Baker, M., Bamforth, F., Beckmann, K., Pino, G., Berberich, S., Binard, R., Boemer, F., Bonham, J., Breen, N., Bryant, S., Caggana, M., Caldwell, S., Camilot, M., Campbell, C., Carducci, C., Bryant, S., Caggana, M., Caldwell, S., Camilot, M., Campbell, C., Carducci, C., Cariappa, R., Carlisle, C., Caruso, U., Cassanello, M., Castilla, A., Ramos, D., Chakraborty, P., Chandrasekar, R., Ramos, A., Cheillan, D., Chien, Y., Childs, T., Chrastina, P., Sica, Y., de Juan, J., Colandre, M., Espinoza, V., Corso, G., Currier, R., Cyr, D., Czuczy, N., D'Apolito, O., Davis, T., de Sain-Van der Velden, M., Delgado Pecellin, C., Di Gangi, I., Di Stefano, C., Dotsikas, Y., Downing, M., Downs, S., Dy, B., Dymerski, M., Rueda, I., Elvers, B., Eaton, R., Eckerd, B., El Mougy, F., Eroh, S., Espada, M., Evans, C., Fawbush, S., Fijolek, K., Fisher, L., Franzson, L., Frazier, D., Garcia, L., Bermejo, M., Gavrilov, D., Gerace, R., Giordano, G., Irazabal, Y., Greed, L., Grier, R., Grycki, E., Gu, X., Gulamali-Majid, F., Hagar, A., Han, L., Hannon, W., Haslip, C., Hassan, F., He, M., Hietala, A., Himstedt, L., Hoffman, G., Hoffman, W., Hoggatt, P., Hopkins, P., Hougaard, D., Hughes, K., Hunt, P., Hwu, W., Hynes, J., Ibarra-González, I., Ingham, C., Ivanova, M., Jacox, W., John, C., Johnson, J., Jónsson, J., Karg, E., Kasper, D., Klopper, B., Katakouzinos, D., Khneisser, I., Knoll, D., Kobayashi, H., Koneski, R., Kozich, V., Kouapei, R., Kohlmueller, D., Kremensky, I., la Marca, G., Lavochkin, M., Lee, S., Lehotay, D., Lemes, A., Lepage, J., Lesko, B., Lewis, B., Lim, C., Linard, S., Lindner, M., Lloyd-Puryear, M., Lorey, F., Loukas, Y., Luedtke, J., Maffitt, N., Magee, J., Manning, A., Manos, S., Marie, S., Hadachi, S., Marquardt, G., Martin, S., Matern, D., Mayfield Gibson, S., Mayne, P., McCallister, T., McCann, M., McClure, J., McGill, J., McKeever, C., McNeilly, B., Morrissey, M., Moutsatsou, P., Mulcahy, E., Nikoloudis, D., Norgaard-Pedersen, B., Oglesbee, D., Oltarzewski, M., Ombrone, D., Ojodu, J., Papakonstantinou, V., Reoyo, S., Park, H., Pasquali, M., Pasquini, E., Patel, P., Pass, K., Peterson, C., Pettersen, R., Pitt, J., Poh, S., Pollak, A., Porter, C., Poston, P., Price, R., Queijo, C., Quesada, J., Randell, E., Ranieri, E., Raymond, K., Reddic, J., Reuben, A., Ricciardi, C., Rinaldo, P., Rivera, J., Roberts, A., Rocha, H., Roche, G., Greenberg, C., Mellado, J., Juan-Fita, M., Ruiz, C., Ruoppolo, M., Rutledge, S., Ryu, E., Saban, C., Sahai, I., García-Blanco, M., Santiago-Borrero, P., Schenone, A., Schoos, R., Schweitzer, B., Scott, P., Seashore, M., Seeterlin, M., Sesser, D., Sevier, D., Shone, S., Sinclair, G., Skrinska, V., Stanley, E., Strovel, E., Jones, A., Sunny, S., Takats, Z., Tanyalcin, T., Teofoli, F., Thompson, J., Tomashitis, K., Domingos, M., Torres, J., Torres, R., Tortorelli, S., Turi, S., Turner, K., Tzanakos, N., Valiente, A., Vallance, H., Vela-Amieva, M., Vilarinho, L., von Döbeln, U., Vincent, M., Vorster, B., Watson, M., Webster, D., Weiss, S., Wilcken, B., Wiley, V., Williams, S., Willis, S., Woontner, M., Wright, K., Yahyaoui, R., Yamaguchi, S., Yssel, M., Zakowicz, W. (2011), Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genetics in Medicine. 13(3), 230-254. [Abstract]
  • Wilcken, B., Wiley, V. (2011), Increased iodine deficiency in Victoria, Australia: analysis of neonatal thyroid-stimulating hormone data, 2001 to 2006. The Medical Journal of Australia. , 209-210. [Abstract]

2010

   
  • Wilcken, B. (2010), Fatty acid oxidation disorders: outcome and long-term prognosis. Journal of inherited metabolic disease. 33(5), 501-6. [Abstract]
  • Wilcken, B. (2010), Expanded newborn screening: reducing harm, assessing benefit. Journal of inherited metabolic disease. 33, S205-10. [Abstract]
  • Wortmann, S., Kremer, B., Graham, A., Willemsen, M., Loupatty, F., Hogg, S., Engelke, U., Kluijtmans, L., Wanders, R., Illsinger, S., Wilcken, B., Cruysberg, J., Das, A., Morava, E., Wevers, R. (2010), 3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy. Neurology. 75(12), 1079-1083. [Abstract]
  • Willemsen, M., Verbeek, M., Kamsteeg, E., de Rijk-van Andel, J., Aeby, A., Blau, N., Burlina, A., Donati, M., Geurtz, B., Grattan-Smith, P., Haeussler, M., Hoffmann, G., Jung, H., de Klerk, J., van der Knaap, M., Kok, F., Leuzzi, V., de Lonlay, P., Megarbane, A., Monaghan, H., Renier, W., Rondot, P., Ryan, M., Seeger, J., Smeitink, J., Steenbergen-Spanjers, G., Wassmer, E., Weschke, B., Wijburg, F., Wilcken, B., Zafeiriou, D., Wevers, R. (2010), Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain : a journal of neurology. 133(6), 1810-22. [Abstract]
  • Khalid, J., Oerton, J., Besley, G., Dalton, N., Downing, M., Green, A., Henderson, M., Krywawych, S., Wiley, V., Wilcken, B., Dezateux, C. (2010), Relationship of Octanoylcarnitine Concentrations to Age at Sampling in Unaffected Newborns Screened for Medium-Chain Acyl-CoA Dehydrogenase Deficiency. Clinical chemistry. 56(6), 1015-21. [Abstract]
  • Warne, G., Armstrong, K., Faunce, T., Wilcken, B., Boneh, A., Geelhoed, E., Craig, M. (2010), The case for newborn screening for congenital adrenal hyperplasia in Australia. The Medical Journal of Australia. , 107. [Abstract]
  • Balasubramaniam, S., Rudduck, C., Bennetts, B., Peters, G., Wilcken, B., Ellaway, C. (2010), Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Molecular genetics and metabolism. 99(1), 34-41. [Abstract]
  • Spiekerkoetter, U., Bastin, J., Gillingham, M., Morris, A., Wijburg, F., Wilcken, B. (2010), Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. Journal of Inherited Metabolic Disease. 33(5), 555-561. [Abstract]

2009

   
  • Wilcken, B. (2009), Cystic fibrosis: refining the approach to newborn screening. The Journal of Pediatrics. 155, 605-606. [Abstract]
  • Wilcken, B., Haas, M., Joy, P., Wiley, V., Bowling, F., Carpenter, K., Christodoulou, J., Cowley, D., Ellaway, C., Fletcher, J., Kirk, E., Lewis, B., McGill, J., Peters, H., Pitt, J., Ranieri, E., Yaplito-Lee, J., Boneh, A. (2009), Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years. Pediatrics. 124(2), e241-e248. [Abstract]
  • Cunningham, S., Spinoulas, A., Carpenter, K., Wilcken, B., Kuchel, P., Alexander, I. (2009), AAV2/8-mediated Correction of OTC Deficiency Is Robust in Adult but Not Neonatal Spf(ash) Mice. Molecular Therapy. 17(8), 1340-1346. [Abstract]
  • Castellani, C., Southern, K., Brownlee, K., Dankert Roelse, J., Duff, A., Farrell, M., Mehta, A., Munck, A., Pollitt, R., Sermet-Gaudelus, I., Wilcken, B., Ballmann, M., Corbetta, C., de Monestrol, I., Farrell, P., Feilcke, M., Férec, C., Gartner, S., Gaskin, K., Hammermann, J., Kashirskaya, N., Loeber, G., Macek, M., Mehta, G., Reiman, A., Rizzotti, P., Sammon, A., Sands, D., Smyth, A., Sommerburg, O., Torresani, T., Travert, G., Vernooij, A., Elborn, S. (2009), European best practice guidelines for cystic fibrosis neonatal screening. Journal of Cystic Fibrosis. 8(3), 153-173. [Abstract]
  • Norman, R., Haas, M., Wilcken, B. (2009), International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions. Health policy (Amsterdam, Netherlands). 89(0), 252-60. [Abstract]
  • Norman, R., Haas, M., Chaplin, M., Joy, P., Wilcken, B. (2009), Economic evaluation of tandem mass spectrometry newborn screening in Australia. Pediatrics. 123(2), 451-457. [Abstract]
  • Joy, P., Black, C., Rocca, A., Haas, M., Wilcken, B. (2009), Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): The impact of early diagnosis and screening on outcome. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 15(1), 8-20. [Abstract]

2008

   
  • Wilcken, B. (2008), Disorders of the carnitine cycle and detection by newborn screening. Annals of the Academy of Medicine, Singapore. 37(12 Suppl), 71-73. [Abstract]
  • Wilcken, B. (2008), Improving child health--newborn screening for all?. Annals of the Academy of Medicine, Singapore. 37(12 Suppl), 3. [Abstract]
  • Wilcken, B. (2008), Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: the negative case. Annals of the Academy of Medicine, Singapore. 37(12 Suppl), 36-33. [Abstract]
  • McKay, K., Wilcken, B. (2008), Newborn screening for cystic fibrosis offers an advantage over symptomatic diagnosis for the long term benefit of patients: the motion for. Paediatric Respiratory Reviews. 9(4), 290-294. [Abstract]
  • Gleeson, H., Wiley, V., Wilcken, B., Elliott, E., Cowell, C., Thonsett, M., Byrne, G., Ambler, G. (2008), Two-year pilot study of newborn screening for congenital adrenal hyperlasia in New South Wales compared with nationwide case surveillance in Australia. Journal of Paediatrics and Child Health. 44(10), 554-559. [Abstract]
  • Bijarnia, S., Wiley, V., Carpenter, K., Christodoulou, J., Ellaway, C., Wilcken, B. (2008), Glutaric aciduria type I: outcome following detection by newborn screening. Journal of inherited metabolic disease. 31(4), 503-7. [Abstract]
  • Hackett, A., Gillard, J., Wilcken, B. (2008), n of 1 trial for an ornithine transcarbamylase deficiency carrier. Molecular Genetics and Metabolism. 94(2), 157-161. [Abstract]
  • Wilcken, B. (2008), Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. Journal of paediatrics and child health. , 232-233; author reply 233. [Abstract]
  • Wilcken, B. (2008), The consequences of extended newborn screening programmes: Do we know who needs treatment?. Journal of Inherited Metabolic Disease. 0(0), 0. [Abstract]
  • Wilcken, B. (2008), More on medium-chain acyl-coenzyme a dehydrogenase deficiency in a neonate. The New England journal of medicine. , 647; author reply 647. [Abstract]
  • Wilcken, B., Wiley, V. (2008), Newborn screening. Pathology. 40(2), 104-115. [Abstract]